
Sign up to save your podcasts
Or


GLP-1 agonists are transforming medicine in ways few could have predicted. In this captivating conversation, naturopathic physician Dr. Tina Moore challenges the conventional narrative around these medications, revealing their potential beyond weight loss and diabetes management.
When Dr. Tina first began researching GLP-1s, she discovered a wealth of overlooked studies showing profound effects on inflammation, autoimmunity, and regenerative healing. Despite facing significant pushback from colleagues who expected a naturopathic doctor to reject pharmaceutical interventions, she couldn't ignore the compelling evidence. What she found most remarkable was how these peptides—which naturally occur in our bodies—could address multiple health issues simultaneously through their "pleiotropic" effects.
The conversation ventures into territory rarely discussed in mainstream medical circles: how lower, personalized doses might provide optimal benefits while minimizing side effects. Dr. Tina shares striking clinical observations, including her own experience with Hashimoto's thyroiditis improving dramatically on a micro-dose regimen. Patients report unexpected improvements in conditions ranging from rheumatoid arthritis to depression to addictive behaviors—benefits that appear independent of weight loss.
Most fascinating is Dr. Tina's perspective on dosing strategy. While conventional protocols typically start higher and escalate quickly, this approach risks receptor desensitization and excessive AMPK pathway activation, potentially causing disproportionate muscle loss. She advocates for "slow and low" dosing, tailored to individual needs, working alongside comprehensive lifestyle changes.
The discussion also tackles accessibility issues, comparing compounded options with brand-name medications, and speculates about future developments that might make these treatments more affordable and personalized. If you're curious about metabolic health, inflammation, or the future of medicine, this conversation offers a refreshingly nuanced perspective that cuts through polarized debates with evidence-based insights.
https://www.drtyna.com/
https://www.gatlan.com/
Continue this conversation on SubStack: https://robertlufkinmd.substack.com
Lies I Taught In Medical School : Free sample chapter- https://www.robertlufkinmd.com/lies/
Web: https://robertlufkinmd.com/
X: https://x.com/robertlufkinmd
Youtube: https://www.youtube.com/robertLufkinmd
Instagram: https://www.instagram.com/robertlufkinmd/
LinkedIn: https://www.linkedin.com/in/robertlufkinmd/
TikTok: https://www.tiktok.com/@robertlufkin
Threads: https://www.threads.net/@robertlufkinmd
Facebook: https://www.facebook.com/robertlufkinmd
Bluesky: https://bsky.app/profile/robertlufkinmd.bsky.social
Mastodon: ...
By Robert Lufkin MD4.4
2121 ratings
GLP-1 agonists are transforming medicine in ways few could have predicted. In this captivating conversation, naturopathic physician Dr. Tina Moore challenges the conventional narrative around these medications, revealing their potential beyond weight loss and diabetes management.
When Dr. Tina first began researching GLP-1s, she discovered a wealth of overlooked studies showing profound effects on inflammation, autoimmunity, and regenerative healing. Despite facing significant pushback from colleagues who expected a naturopathic doctor to reject pharmaceutical interventions, she couldn't ignore the compelling evidence. What she found most remarkable was how these peptides—which naturally occur in our bodies—could address multiple health issues simultaneously through their "pleiotropic" effects.
The conversation ventures into territory rarely discussed in mainstream medical circles: how lower, personalized doses might provide optimal benefits while minimizing side effects. Dr. Tina shares striking clinical observations, including her own experience with Hashimoto's thyroiditis improving dramatically on a micro-dose regimen. Patients report unexpected improvements in conditions ranging from rheumatoid arthritis to depression to addictive behaviors—benefits that appear independent of weight loss.
Most fascinating is Dr. Tina's perspective on dosing strategy. While conventional protocols typically start higher and escalate quickly, this approach risks receptor desensitization and excessive AMPK pathway activation, potentially causing disproportionate muscle loss. She advocates for "slow and low" dosing, tailored to individual needs, working alongside comprehensive lifestyle changes.
The discussion also tackles accessibility issues, comparing compounded options with brand-name medications, and speculates about future developments that might make these treatments more affordable and personalized. If you're curious about metabolic health, inflammation, or the future of medicine, this conversation offers a refreshingly nuanced perspective that cuts through polarized debates with evidence-based insights.
https://www.drtyna.com/
https://www.gatlan.com/
Continue this conversation on SubStack: https://robertlufkinmd.substack.com
Lies I Taught In Medical School : Free sample chapter- https://www.robertlufkinmd.com/lies/
Web: https://robertlufkinmd.com/
X: https://x.com/robertlufkinmd
Youtube: https://www.youtube.com/robertLufkinmd
Instagram: https://www.instagram.com/robertlufkinmd/
LinkedIn: https://www.linkedin.com/in/robertlufkinmd/
TikTok: https://www.tiktok.com/@robertlufkin
Threads: https://www.threads.net/@robertlufkinmd
Facebook: https://www.facebook.com/robertlufkinmd
Bluesky: https://bsky.app/profile/robertlufkinmd.bsky.social
Mastodon: ...

780 Listeners

7,226 Listeners

5,012 Listeners

1,536 Listeners

290 Listeners

717 Listeners

3,461 Listeners

9,191 Listeners

1,820 Listeners

1,098 Listeners

843 Listeners

301 Listeners

244 Listeners

188 Listeners

114 Listeners